Search Results - Marrero Santos, Carmen Milagros

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Obinutuzumab plus bendamustine for relapsed/refractory chronic lymphocytic leukemia and predictive and prognostic impact of genetic alterations: the phase II GABRIELL study

    Obinutuzumab plus bendamustine for relapsed/refractory chronic lymphocytic leukemia and predictive and prognostic impact of genetic alterations: the phase II GABRIELL study by Bravo, Julio, Baltasar Tello, Patricia, González Garcia, Esther, Ríos Herranz, Eduardo, Páyer, Angel Ramirez, Terol Castera, María José, Champ, Diana, Medina Perez, Angeles, Gironella, Mercedes, Fernández Zarzoso, Miguel, Forés, Rafael, Delgado, Julio, Garcia-Marco, José A.

    Published in Leukemia & lymphoma
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  2. 2
    Phase II Trial to Evaluate the Efficacy and Safety of the Combination of Obinutuzumab and Bendamustine Treatment in Patients (Pts) with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

    Phase II Trial to Evaluate the Efficacy and Safety of the Combination of Obinutuzumab and Bendamustine Treatment in Patients (Pts) with Relapsed/Refractory Chronic Lymphocytic Leuk... by Garcia-Marco, Jose, Baltasar Tello, Patricia, Garcia, Esther González, Ríos Herranz, Eduardo, Ramirez Payer, Angel, Terol Castera, María José, Champ, Diana, Medina Perez, Angeles, Gironella, Mercedes, Rodríguez Fernández, Alicia, Muntañola Prat, Ana, Suárez Cabrera, Alexia, Jurado Chacón, Manuel, Fernández Zarzoso, Miguel, Rodríguez, Mercedes, Clavel, Juana, Dourdil Sahun, Maria Victoria, Ferra Coll, Christelle M, Pérez Persona, Ernesto, Marrero Santos, Carmen Milagros, Forés, Rafael, Delgado, Julio

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: